<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: irregular heartbeat</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Many people with implantable defibrillators can participate in vigorous sports</title>
   	 <description>Many people with implantable defibrillators can safely participate in vigorous sports according to new research in the American Heart Association journal Circulation.</description>
     <link>http://medicalxpress.com/news/2013-05-sports-heart-zapping-device.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 20 May 2013 18:00:01 EST</pubDate>
	 <guid isPermaLink="false">news288291001</guid>
	 
</item>
<item>
     <title>Australia: Stroke rates decline, but many still preventable</title>
   	 <description>The rate of strokes suffered by Australians has dropped over the past 20 years, while strokes caused by an irregular heartbeat now account for one third of all strokes, according to new research led by the University of Adelaide.</description>
     <link>http://medicalxpress.com/news/2013-05-australia-decline.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 16 May 2013 06:03:51 EST</pubDate>
	 <guid isPermaLink="false">news287903022</guid>
	 
</item>
<item>
     <title>Kcentra approved to stop severe bleeding in heart patients</title>
   	 <description>(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and similar products.</description>
     <link>http://medicalxpress.com/news/2013-04-kcentra-severe-heart-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 30 Apr 2013 13:50:01 EST</pubDate>
	 <guid isPermaLink="false">news286547963</guid>
	 
</item>
<item>
     <title>World's most detailed 3-D computer model of heart chambers</title>
   	 <description>Researchers from The University of Auckland have developed the world's most detailed 3D computer models of the heart's upper chambers.</description>
     <link>http://medicalxpress.com/news/2013-04-world-d-heart-chambers.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 04 Apr 2013 10:43:38 EST</pubDate>
	 <guid isPermaLink="false">news284291011</guid>
	 
</item>
<item>
     <title>Stroke prevention device misses key goal in study</title>
   	 <description>The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat.</description>
     <link>http://medicalxpress.com/news/2013-03-device-key-goal.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 09 Mar 2013 15:12:15 EST</pubDate>
	 <guid isPermaLink="false">news282064316</guid>
	 
</item>
<item>
     <title>Clogged heart arteries can foreshadow stroke</title>
   	 <description>Blockages in your heart arteries could mean you're more likely to have a stroke, even if you're considered low risk, according to research in the American Heart Association journal Stroke.</description>
     <link>http://medicalxpress.com/news/2013-02-clogged-heart-arteries-foreshadow.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 28 Feb 2013 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281281975</guid>
	 
</item>
<item>
     <title>FDA clears anticlotting drug Eliquis</title>
   	 <description>The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes and heart attacks.</description>
     <link>http://medicalxpress.com/news/2012-12-fda-anticlotting-drug-eliquis.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 28 Dec 2012 17:54:15 EST</pubDate>
	 <guid isPermaLink="false">news275939650</guid>
	 
</item>
<item>
     <title>Bristol-Myers, Pfizer's Eliquis approved in Japan</title>
   	 <description>Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart attacks. But that's only if it can win U.S. approval, as two rival drugs have done.</description>
     <link>http://medicalxpress.com/news/2012-12-bristol-myers-pfizer-eliquis-japan.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 26 Dec 2012 14:43:13 EST</pubDate>
	 <guid isPermaLink="false">news275755378</guid>
	 
</item>
<item>
     <title>How dangerous are energy drinks for young people?</title>
   	 <description>(Medical Xpress)—News reports broke this week that since 2003, three Canadian teens have died from drinking energy drinks, and 35 others have suffered series side effects like amnesia and irregular heartbeat. Young people are increasingly turning to energy drinks to fuel study sessions, as well as coming to rely on them in everyday life. But according to a U of T caffeine expert, these kids are playing a dangerous game.</description>
     <link>http://medicalxpress.com/news/2012-11-dangerous-energy-young-people.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 21 Nov 2012 08:18:15 EST</pubDate>
	 <guid isPermaLink="false">news272708164</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/howdangerous.jpg" width="90" height="90" />
</item>
<item>
     <title>Bristol-Pfizer anticlot drug gets key EU approval</title>
   	 <description>European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.</description>
     <link>http://medicalxpress.com/news/2012-11-bristol-pfizer-anticlot-drug-key-eu.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 20 Nov 2012 16:39:37 EST</pubDate>
	 <guid isPermaLink="false">news272651965</guid>
	 
</item>
<item>
     <title>Expert: Time to break the beta blocker habit?</title>
   	 <description>First developed in the 1950s, beta blockers have been a mainstay in medicine for decades, used to treat everything from heart disease to stage fright to glaucoma. But some older classes of beta blockers are causing new concerns.</description>
     <link>http://medicalxpress.com/news/2012-11-expert-beta-blocker-habit.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 12 Nov 2012 05:39:09 EST</pubDate>
	 <guid isPermaLink="false">news271921135</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/experttimeto.jpg" width="90" height="90" />
</item>
<item>
     <title>Fish oil won't prevent irregular heartbeat after cardiac surgery, study says</title>
   	 <description>(HealthDay)—A hoped-for effect of fish oil supplements in preventing an irregular heartbeat that often follows heart surgery did not materialize in a major new trial.</description>
     <link>http://medicalxpress.com/news/2012-11-fish-oil-wont-irregular-heartbeat.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 05 Nov 2012 17:30:05 EST</pubDate>
	 <guid isPermaLink="false">news271358656</guid>
	 
</item>
<item>
     <title>Apixaban superior to warfarin across range of patient risk scores</title>
   	 <description>A new anticoagulant called apixaban is superior to warfarin in preventing stroke with consistent effects across a wide range of stroke and bleeding risk in patients with atrial fibrillation, according to Duke University Medical Center researchers.</description>
     <link>http://medicalxpress.com/news/2012-10-apixaban-superior-warfarin-range-patient.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 01 Oct 2012 18:30:03 EST</pubDate>
	 <guid isPermaLink="false">news268329611</guid>
	 
</item>
<item>
     <title>Many emergency programs get failing grade when it comes to stroke training</title>
   	 <description>Medical residents training to work in the emergency department need more formal stroke training, says a study presented today at the Canadian Stroke Congress, noting that, as the first point of contact in stroke care, they see nearly 100 per cent of stroke patients taken to hospital.</description>
     <link>http://medicalxpress.com/news/2012-10-emergency-grade.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 01 Oct 2012 03:00:44 EST</pubDate>
	 <guid isPermaLink="false">news268279231</guid>
	 
</item>
<item>
     <title>Anti-clot drug recommended for new approval in EU</title>
   	 <description>(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers Squibb Co. and Pfizer Inc. said.</description>
     <link>http://medicalxpress.com/news/2012-09-anti-clot-drug-eu.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 21 Sep 2012 13:09:06 EST</pubDate>
	 <guid isPermaLink="false">news267451731</guid>
	 
</item>
<item>
     <title>Increasing percentage of patients aware of link between atrial fibrillation and stroke</title>
   	 <description>(Medical Xpress)—Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial fibrillation and the correlation between this condition and stroke. </description>
     <link>http://medicalxpress.com/news/2012-09-percentage-patients-aware-link-atrial.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 06 Sep 2012 10:19:48 EST</pubDate>
	 <guid isPermaLink="false">news266145558</guid>
	 
</item>
<item>
     <title>Physicians' focus on risks for stroke and dementia saved lives, money</title>
   	 <description>Fewer people died or needed expensive long-term care when their physicians focused on the top risk factors for stroke and dementia, according to research reported in the Journal of the American Heart Association (JAHA). </description>
     <link>http://medicalxpress.com/news/2012-07-physicians-focus-dementia-money.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 17 Jul 2012 16:00:12 EST</pubDate>
	 <guid isPermaLink="false">news261750736</guid>
	 
</item>
<item>
     <title>New blood thinner may lower chances of clots in high-risk heart patients: FDA</title>
   	 <description>(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.</description>
     <link>http://medicalxpress.com/news/2012-05-blood-thinner-chances-clots-high-risk.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 21 May 2012 21:30:01 EST</pubDate>
	 <guid isPermaLink="false">news256843717</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newbloodthin.jpg" width="90" height="90" />
</item>
<item>
     <title>Thyroid condition linked to heart problems: study</title>
   	 <description>(HealthDay) -- New evidence suggests that a type of overactive thyroid condition appears to boost the risk of heart problems, especially atrial fibrillation (a form of irregular heartbeat) and premature death.</description>
     <link>http://medicalxpress.com/news/2012-04-thyroid-condition-linked-heart-problems.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 25 Apr 2012 19:10:01 EST</pubDate>
	 <guid isPermaLink="false">news254593945</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/thyroidcondi.jpg" width="90" height="84" />
</item>
<item>
     <title>Stroke risk high when anti-clotting drugs stopped</title>
   	 <description>Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging Science Series webinar.</description>
     <link>http://medicalxpress.com/news/2012-04-high-anti-clotting-drugs.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 25 Apr 2012 13:02:57 EST</pubDate>
	 <guid isPermaLink="false">news254577764</guid>
	 
</item>
<item>
     <title>Osteoporosis drugs may increase risk of serious eye disease</title>
   	 <description>Drugs that are commonly used to prevent osteoporosis may increase the risk of serious inflammatory eye disease in first-time users, found an article in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2012-04-osteoporosis-drugs-eye-disease.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Mon, 02 Apr 2012 12:00:10 EST</pubDate>
	 <guid isPermaLink="false">news252584667</guid>
	 
</item>
<item>
     <title>Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure</title>
   	 <description>(Medical Xpress) -- Researchers have identified genetic causes in nearly 1 in 5 patients who suffer a type of heart failure called dilated cardiomyopathy.</description>
     <link>http://medicalxpress.com/news/2012-03-genetic-patients-dilated-cardiomyopathy-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 27 Mar 2012 07:52:23 EST</pubDate>
	 <guid isPermaLink="false">news252053513</guid>
	 
</item>
<item>
     <title>Stroke-preventing technology demonstrated in JoVE</title>
   	 <description>In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be affected by 2050. The most devastating side effect of AF is stroke, but a new device from Boston Scientific may prevent them from occurring.</description>
     <link>http://medicalxpress.com/news/2012-02-stroke-preventing-technology-jove.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 28 Feb 2012 10:29:15 EST</pubDate>
	 <guid isPermaLink="false">news249647343</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/strokepreven.jpg" width="90" height="90" />
</item>
<item>
     <title>Irregular heartbeat strong predictor of decline in people at risk of heart disease</title>
   	 <description>An irregular heartbeat -- atrial fibrillation -- is a strong predictor of cognitive decline and the loss of independence in daily activities in older people at risk of cardiovascular disease, according to a study in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2012-02-irregular-heartbeat-strong-predictor-decline.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 27 Feb 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news249565244</guid>
	 
</item>
<item>
     <title>Researchers solve puzzle of proteins linked to heart failure</title>
   	 <description>Sudden cardiac death is a risk for patients with heart failure because the calcium inside their heart cells is not properly controlled and this can lead to an irregular heartbeat. New findings published in PLoS ONE, which reveal mechanisms that underlie this life-threatening risk, provide new possibilities for fighting it.</description>
     <link>http://medicalxpress.com/news/2012-02-puzzle-proteins-linked-heart-failure.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 22 Feb 2012 12:03:57 EST</pubDate>
	 <guid isPermaLink="false">news249134627</guid>
	 
</item>
<item>
     <title>Atrial arrhythmias detected by pacemakers increase risk of stroke</title>
   	 <description>An irregular heartbeat that you don't even feel but can be picked up by a pacemaker is associated with a significantly increased risk of stroke, says a new McMaster University study.</description>
     <link>http://medicalxpress.com/news/2012-01-atrial-arrhythmias-pacemakers.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 11 Jan 2012 17:49:29 EST</pubDate>
	 <guid isPermaLink="false">news245526560</guid>
	 
</item>
<item>
     <title>Study finds warfarin underutilized in women</title>
   	 <description>Dr. Rabab Mohsin, an internal medicine resident at the University of Kentucky, working with Dr. Alison Bailey of the University of Kentucky Gill Heart Institute, has discovered that the drug warfarin was underutilized in a large study group of women.</description>
     <link>http://medicalxpress.com/news/2011-12-warfarin-underutilized-women.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 13 Dec 2011 11:40:03 EST</pubDate>
	 <guid isPermaLink="false">news242996577</guid>
	 
</item>
<item>
     <title>New method for safer dosing of anticoagulants</title>
   	 <description>Elderly people with atrial fibrillation are often treated with anticoagulants to thin the blood, but this medicine is hard to dose and patients have to have their blood tested regularly. Researchers at the Sahlgrenska Academy at the University of Gothenburg and Chalmers University of Technology have now devised a new method that improves the accuracy of risk assessments.</description>
     <link>http://medicalxpress.com/news/2011-12-method-safer-dosing-anticoagulants.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 06 Dec 2011 13:48:14 EST</pubDate>
	 <guid isPermaLink="false">news242401682</guid>
	 
</item>
<item>
     <title>The Medical Minute: Atrial Fibrillation -- What is It?</title>
   	 <description>Atrial fibrillation (AF) is the most common heart rhythm disturbance in the United States and affects 2 to 4 million Americans. It is usually a disease of aging, however it can affect people of all ages -- 1 percent of people under age 60 and 10 percent of all people over age 80 have AF.</description>
     <link>http://medicalxpress.com/news/2011-10-medical-minute-atrial-fibrillation-.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 06 Oct 2011 05:54:36 EST</pubDate>
	 <guid isPermaLink="false">news237099242</guid>
	 
</item>
<item>
     <title>Loyola testing new device for treating Atrial Fibrillation</title>
   	 <description>Loyola University Medical Center is testing a high-tech catheter device that's intended to improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.</description>
     <link>http://medicalxpress.com/news/2011-09-loyola-device-atrial-fibrillation.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 15 Sep 2011 14:24:05 EST</pubDate>
	 <guid isPermaLink="false">news235315427</guid>
	 
</item>


</channel>
</rss>
